Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Bespoke Biotherapeutics
AddedFeb 18, 2024
UpdatedJun 18, 2026
Bespoke Biotherapeutics

Bespoke Biotherapeutics

Bespoke Biotherapeutics: Innovating custom B-cell therapies for enhanced cancer immunotherapy.

HQ
San Mateo, CA, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Bespoke Biotherapeutics, founded with a mission to revolutionize cancer treatment, specializes in engineered B-cell therapeutics. The company aims to enhance the natural immune response and address the limitations of existing immunotherapies. Their core services include customized B-cell sourcing, isolation, activation, culture expansion, and non-viral genetic engineering, all tailored to optimize commercial B-cell products for infusion. Bespoke Biotherapeutics is focused on the biotechnology market, particularly in the field of cancer immunotherapy.

Notable affiliated individuals include leading scientists and researchers in immunotherapy and genetic engineering. The company has garnered attention for its innovative approach and has been featured in prominent scientific publications such as Nature and Cancer Cell. Key achievements include advancements in CRISPR/Cas9 targeted nuclease technology for engineering primary human B-cells. Bespoke Biotherapeutics is making a significant impact by offering novel, customized living drugs that promise to improve the efficacy of cancer treatments.

Bespoke Biotherapeutics - Similar Companies

Be Biopharma logo

Be Biopharma

Cellective BioTherapy logo

Cellective BioTherapy

Cell BioEngines logo

Cell BioEngines

cellbioengines.com

Fresh Wind Biotechnologies USA logo

Fresh Wind Biotechnologies USA

Outpace Bio logo

Outpace Bio

outpacebio.com

Fuse Biotherapeutics logo

Fuse Biotherapeutics

fusebiotx.com

Ernexa Therapeutics logo

Ernexa Therapeutics

eternatx.com

Cellular Approaches logo

Cellular Approaches

Larkspur Biosciences logo

Larkspur Biosciences

larkspur.bio

Walking Fish Therapeutics logo

Walking Fish Therapeutics

HebeCell logo

HebeCell

hebecellcorp.com

Creative BioTherapeutics logo

Creative BioTherapeutics

creativebio.tech

Immpact Bio logo

Immpact Bio

immpact-bio.com

ManaT Bio logo

ManaT Bio

clasptx.com

Modulus Therapeutics logo

Modulus Therapeutics

Bespoke Biotherapeutics - Quick Facts

Who are Bespoke Biotherapeutics' competitors?

Companies similar to Bespoke Biotherapeutics include Be Biopharma, Cellective BioTherapy, Cell BioEngines and Fresh Wind Biotechnologies USA.

When was Bespoke Biotherapeutics founded?

Bespoke Biotherapeutics was founded in 2021.

Where is Bespoke Biotherapeutics' headquarters located?

Bespoke Biotherapeutics' headquarters is located in San Mateo, CA, US.

When was Bespoke Biotherapeutics' last funding round?

Bespoke Biotherapeutics' most recent funding round was for $256k (USD) in June 2022.

How much has Bespoke Biotherapeutics raised to-date?

As of Jun 17, 2022, Bespoke Biotherapeutics has raised a total of $256k (USD).

How many employees does Bespoke Biotherapeutics have?

Bespoke Biotherapeutics has 2 employees as of Feb 4, 2024.

Bespoke Biotherapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Software
Customer
  • Enterprise
Main Product
  • B-Cell Therapeutics
Tags
  • Consulting
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research